100Xfounder
Get Featured

Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

About Vaccitech

The Problem Vaccitech addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.

The Solution Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research In practice, Vaccitech centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.

Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Vaccitech is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.

Why it Matters

Vaccitech matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Vaccitech is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Funding Snapshot

Total Funding: $290.00MLast Round: IPO Sequoia, Post-IPO, $290M valuationAll Rounds: 1
  • IPOSequoia, Post-IPO, $290M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: February 23, 2026

Vaccitech intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Vaccitech.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Vaccitech

Common questions people ask about this profile.

What is Vaccitech?

Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

Who founded Vaccitech?

Vaccitech is associated with Vaccitech Team on 100Xfounder.

Where is Vaccitech located?

Vaccitech is listed in London, England, United Kingdom.

What stage is Vaccitech in?

Vaccitech is currently mapped to Ipo. Funding context: Sequoia, Post-IPO, $290M valuation

What is the latest funding round of Vaccitech?

Vaccitech's latest tracked round is IPO Sequoia, Post-IPO, $290M valuation. Total tracked rounds: 1.

Is Vaccitech hiring now?

Vaccitech hiring status: Open Roles.

What technologies does Vaccitech use?

Vaccitech is associated with Python, GCP, BigQuery, and React.

Is Vaccitech verified on 100Xfounder?

Yes. Vaccitech is currently marked verified on 100Xfounder as of March 3, 2026.

How can users connect with Vaccitech founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.